Helicase Ventures logo 完稿-03_edited.
  • Home

  • About

  • Team

  • Portfolio

  • Sectors

  • News

  • Contact

  • More

    Use tab to navigate through the menu items.
    • All Posts
    • Portfolio Company News
    • Helicase Press Release
    Search
    Ribbon Biolabs Raises EUR 18 Million Series A Financing for DNA Synthesis Technology
    Admin
    • Jan 30
    • 2 min

    Ribbon Biolabs Raises EUR 18 Million Series A Financing for DNA Synthesis Technology

    VIENNA, AUSTRIA, January 31, 2022 -- Ribbon Biolabs, the DNA synthesis company, today announced the successful close of EUR 18 million in...
    9 views0 comments
    Merck leans into AI with $610M in biobucks for Absci drug discovery pact
    Admin
    • Jan 12
    • 1 min

    Merck leans into AI with $610M in biobucks for Absci drug discovery pact

    VANCOUVER, Wash., Jan. 07, 2022 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), the drug and target discovery company ...
    12 views0 comments
    AbSci sets IPO terms, valuing company at up to $1.5 billion
    Admin
    • Jul 18, 2021
    • 1 min

    AbSci sets IPO terms, valuing company at up to $1.5 billion

    AbSci Corp. ABSI, has set terms of its initial public offering, which could value the Washington-based provider of an artificial...
    28 views0 comments
    Protein discovery and development platform AbSci sets terms for $200 million IPO
    Admin
    • Jul 14, 2021
    • 1 min

    Protein discovery and development platform AbSci sets terms for $200 million IPO

    AbSci, which provides a platform for the discovery and development of proteins and biologics, announced terms for its IPO on Thursday....
    20 views0 comments
    Helicase Venture portfolio company Absci files for IPO
    Admin
    • Jul 12, 2021
    • 2 min

    Helicase Venture portfolio company Absci files for IPO

    https://seekingalpha.com/news/3711566-biotech-discovery-company-absci-files-for-ipo Absci Corp., a synthetic biology company whose...
    22 views0 comments
    Landos Biopharma Announces Positive Outcome of End-of-Phase 2 Meeting with the FDA for Omilancor
    Admin
    • Jun 13, 2021
    • 3 min

    Landos Biopharma Announces Positive Outcome of End-of-Phase 2 Meeting with the FDA for Omilancor

    https://www.globenewswire.com/news-release/2021/06/14/2246385/0/en/Landos-Biopharma-Announces-Positive-Outcome-of-End-of-Phase-2-Meeting-...
    8 views0 comments
    Totient, a Helicase Venture Portfolio Company, has been Acquired by AbSci
    Admin
    • Jun 13, 2021
    • 2 min

    Totient, a Helicase Venture Portfolio Company, has been Acquired by AbSci

    Totient, a Helicase Venture portfolio company, has been acquired by AbSci, a synthetic biology company unlocking the potential of...
    14 views0 comments
    Pipeline Therapeutics Initiates Phase 1 Clinical Trial of PIPE-307
    Admin
    • Mar 1, 2021
    • 2 min

    Pipeline Therapeutics Initiates Phase 1 Clinical Trial of PIPE-307

    SAN DIEGO, March 2, 2021 – Pipeline Therapeutics, a biopharmaceutical company focused on the development and commercialization of...
    8 views0 comments
    Pipeline Therapeutics Completes Oversubscribed $80 Million Series C Financing
    Admin
    • Feb 10, 2021
    • 1 min

    Pipeline Therapeutics Completes Oversubscribed $80 Million Series C Financing

    SAN DIEGO--(BUSINESS WIRE)--Pipeline Therapeutics, a biopharmaceutical company focused on the development and commercialization of...
    18 views0 comments
    Landos Biopharma guns for a $100M IPO to boost AI autoimmune R&D work
    Admin
    • Jan 14, 2021
    • 2 min

    Landos Biopharma guns for a $100M IPO to boost AI autoimmune R&D work

    Landos is based upon the work of CEO Josep Bassaganya-Riera, Ph.D., a serial entrepreneur and Virginia Tech professor who outlined the...
    2 views0 comments
    Pipeline Therapeutics Initiates Phase 1/2a Clinical Trial of PIPE-505 in Sensorineural Hearing Loss
    Admin
    • Jul 22, 2020
    • 3 min

    Pipeline Therapeutics Initiates Phase 1/2a Clinical Trial of PIPE-505 in Sensorineural Hearing Loss

    PIPE-505 is the first small molecule developed specifically for the treatment of sensorineural hearing loss (SNHL) associated with ...
    9 views0 comments
    View More

    ©2022 by Helicase Venture. All rights reserved

    • linkedin